N-of-1 tests in general practice: pharmacological considerations.
Leonore Diezi, Marco Anastasi, Laurent Brutus, Thierry Buclin
Author Information
- Leonore Diezi: Consultant in Clinical Pharmacology, Service of Clinical Pharmacology, Lausanne University Hospital, Lausanne, Switzerland. ORCID
- Marco Anastasi: Pharmacist, Golaz Laboratory, Galenicare SA, Lausanne, Switzerland.
- Laurent Brutus: Department of General Medicine, Faculty of Medicine, Nantes University, Nantes; Multi-Professional Health Care Center, Sallertaine, France. ORCID
- Thierry Buclin: Emeritus Professor of Clinical Pharmacology, Service of Clinical Pharmacology, Lausanne University Hospital, Lausanne, Switzerland. ORCID
No abstract text available.
- Ann Intern Med. 1990 Feb 15;112(4):293-9
[PMID: 2297206]
- Br J Clin Pharmacol. 2022 Oct;88(10):4460-4473
[PMID: 35705532]
- Neurology. 2022 Jan 11;98(2):e174-e185
[PMID: 34675101]
- Heart. 2011 Nov;97(21):1771-5
[PMID: 21586424]
- J Young Pharm. 2010 Apr;2(2):121-9
[PMID: 21264113]
- J R Soc Med. 2017 Aug;110(8):330-340
[PMID: 28776473]
- Neurology. 2006 Oct 24;67(8):1411-20
[PMID: 17060567]
- Pain Ther. 2021 Dec;10(2):1013-1028
[PMID: 34528159]
- Contemp Clin Trials. 2009 Sep;30(5):436-45
[PMID: 19375521]
- J Clin Epidemiol. 2016 Aug;76:9-17
[PMID: 26272792]
- N Engl J Med. 2020 Nov 26;383(22):2182-2184
[PMID: 33196154]
- J Rheumatol. 2006 Oct;33(10):2069-77
[PMID: 17014022]
- Med Care. 2011 Aug;49(8):761-8
[PMID: 21478771]
- J Clin Psychopharmacol. 2018 Jun;38(3):218-225
[PMID: 29596148]
- BMJ. 2021 Feb 24;372:n135
[PMID: 33627334]
